KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Other Non-Current Liabilities: 2012-2024

Historic Other Non-Current Liabilities for TherapeuticsMD (TXMD) over the last 5 years, with Dec 2024 value amounting to $744,000.

  • TherapeuticsMD's Other Non-Current Liabilities rose 23.55% to $871,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $871,000, marking a year-over-year increase of 23.55%. This contributed to the annual value of $744,000 for FY2024, which is 16.98% up from last year.
  • TherapeuticsMD's Other Non-Current Liabilities amounted to $744,000 in FY2024, which was up 16.98% from $636,000 recorded in FY2023.
  • In the past 5 years, TherapeuticsMD's Other Non-Current Liabilities ranged from a high of $2.1 million in FY2021 and a low of $636,000 during FY2023.
  • Its 3-year average for Other Non-Current Liabilities is $829,000, with a median of $744,000 in 2024.
  • Per our database at Business Quant, TherapeuticsMD's Other Non-Current Liabilities plummeted by 48.25% in 2022 and then climbed by 16.98% in 2024.
  • Over the past 4 years, TherapeuticsMD's Other Non-Current Liabilities (Yearly) stood at $2.1 million in 2021, then tumbled by 48.25% to $1.1 million in 2022, then tumbled by 42.55% to $636,000 in 2023, then rose by 16.98% to $744,000 in 2024.